Dolby Laboratories, Inc. (NYSE:DLB – Free Report) – Zacks Research cut their Q4 2024 earnings estimates for Dolby Laboratories in a research report issued on Tuesday, October 29th. Zacks Research analyst V. Doshi now anticipates that the electronics maker will post earnings of $0.43 per share for the quarter, down from their previous forecast of $0.44. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.72 per share. Zacks Research also issued estimates for Dolby Laboratories’ Q2 2025 earnings at $0.85 EPS, Q4 2025 earnings at $0.63 EPS and FY2025 earnings at $2.68 EPS.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The electronics maker reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.14. Dolby Laboratories had a net margin of 16.87% and a return on equity of 10.66%. The firm had revenue of $288.82 million during the quarter, compared to analysts’ expectations of $286.26 million.
Get Our Latest Analysis on Dolby Laboratories
Dolby Laboratories Price Performance
DLB opened at $72.96 on Thursday. Dolby Laboratories has a 12-month low of $66.35 and a 12-month high of $90.06. The stock has a market capitalization of $6.96 billion, a PE ratio of 33.32 and a beta of 0.97. The firm’s fifty day moving average price is $72.82 and its 200 day moving average price is $76.55.
Institutional Investors Weigh In On Dolby Laboratories
Several institutional investors and hedge funds have recently bought and sold shares of the business. Van ECK Associates Corp grew its holdings in shares of Dolby Laboratories by 40.0% during the third quarter. Van ECK Associates Corp now owns 34,881 shares of the electronics maker’s stock valued at $2,535,000 after purchasing an additional 9,967 shares during the last quarter. Harbor Capital Advisors Inc. boosted its position in Dolby Laboratories by 19.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 2,435 shares of the electronics maker’s stock valued at $186,000 after purchasing an additional 390 shares during the period. Cambiar Investors LLC grew its stake in Dolby Laboratories by 0.7% during the 3rd quarter. Cambiar Investors LLC now owns 137,000 shares of the electronics maker’s stock worth $10,485,000 after buying an additional 905 shares during the last quarter. State of Alaska Department of Revenue increased its position in Dolby Laboratories by 143.6% in the third quarter. State of Alaska Department of Revenue now owns 27,937 shares of the electronics maker’s stock worth $2,137,000 after buying an additional 16,470 shares during the period. Finally, Boston Trust Walden Corp increased its position in Dolby Laboratories by 185.3% in the third quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker’s stock worth $82,276,000 after buying an additional 698,283 shares during the period. Institutional investors and hedge funds own 58.56% of the company’s stock.
Insider Activity
In related news, CEO Kevin J. Yeaman sold 28,512 shares of the firm’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the transaction, the chief executive officer now directly owns 83,721 shares in the company, valued at $6,205,400.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 39.54% of the company’s stock.
Dolby Laboratories Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Monday, August 19th were issued a $0.30 dividend. The ex-dividend date was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.64%. Dolby Laboratories’s dividend payout ratio (DPR) is 54.79%.
Dolby Laboratories declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, August 7th that permits the company to buyback $350.00 million in shares. This buyback authorization permits the electronics maker to buy up to 5% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s board believes its stock is undervalued.
About Dolby Laboratories
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
See Also
- Five stocks we like better than Dolby Laboratories
- Stock Dividend Cuts Happen Are You Ready?
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- 3 Warren Buffett Stocks to Buy Now
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.